Data concerning the concentration of dioxins (PCDD/PCDFs), polychlorinated biphenyls (PCBs), metals, metalloids, pesticides and antimicrobials residues are reported for the edible portion of Australian wild and farmed southern bluefin tuna (Thunnus maccoyii). In 2004 wild caught (n=5) and farmed (n=26) southern bluefin tuna (SBT) were collected. The mean concentration of total mercury on a fresh weight (fw) basis was 0.34 mg/kg in wild SBT and 0.31 mg/kg in farmed SBT. Concentrations of dioxins (PCDD/PCDFs) and polychlorinated biphenyls (PCBs) found in wild SBT were extremely low. The mean concentration (fw) of the sum of PCDD/PCDFs and the dioxin-like PCBs was 0.27 pg TEQ/g in wild SBT and 0.61 pg TEQ/g in farmed SBT. Mean PCB total concentration (fw basis) was 0.47 ng/g in wild SBT and 6.60 ng/g in farmed SBT. No detectable residues of any pesticide or antimicrobial compounds were found. All residues detected were within regulatory limits set by the Japanese Competent Authority, the Ministry of Health, Labour and Welfare (MHLW) and the Australian Competent Authority, Food Standards Australia New Zealand (FSANZ). The need for harmonisation of international product integrity procedures for bluefin tunas in international trade is highlighted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.chemosphere.2008.02.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies.
Pharmaceutics
September 2024
Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Schlossgarten 4, 91054 Erlangen, Germany.
Article Synopsis
- Cyclin-dependent kinase 8 (CDK8) helps control how viruses, especially the human cytomegalovirus (HCMV), grow in our cells by affecting important processes in their life cycles.
- Scientists tested some drugs that stop CDK8 to see if they could help fight HCMV, and they found that these drugs made the virus grow much less in cell cultures.
- The research showed that CDK8 is crucial for HCMV's later stages of growth, and using CDK8 inhibitors together with other treatments could work really well against the virus.
Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor.
Curr Issues Mol Biol
August 2024
Department of Obstetrics and Gynecology, Shimane University Faculty of Medicine, Izumo 693-8501, Japan.
Article Synopsis
- Ovarian cancer is categorized into two types: low-grade serous carcinoma (LGSC), which arises from serous borderline tumors (SBT), and high-grade serous carcinoma (HGSC), typically originating from serous tubal intraepithelial carcinoma (STIC).
- The case study discusses a patient diagnosed with stage IIIC HGSC, who also had SBT and LGSC, highlighting the complexities in the cancer's development and treatment.
- Despite undergoing surgery and chemotherapy (TC + bevacizumab), the tumor was resistant to treatment and exhibited mutations, with p53 dysfunction believed to play a role in the transformation from SBT/LGSC to HGSC.
Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.
Cells
August 2024
Division of Bioinformatics, Institute of Biochemistry, FAU, 91054 Erlangen, Germany.
Herpesviral protein kinases, such as the therapy-relevant pUL97 of human cytomegalovirus (HCMV), are important for viral replication efficiency as well as pathogenesis, and represent key antiviral drug targets. HCMV pUL97 is a viral cyclin-dependent kinase (CDK) ortholog, as it shares functional and structural properties with human CDKs. Recently, the formation of vCDK/pUL97-cyclin complexes and the phosphorylation of a variety of viral and cellular substrate proteins has been demonstrated.
View Article and Find Full Text PDFEosinophilic Cells in Ovarian Borderline Serous Tumors as a Predictor of BRAF Mutation.
Cancers (Basel)
June 2024
National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of the Ministry of Health of Russia, Bldg. 4, Oparina Street, 117513 Moscow, Russia.
According to recent reports, ovarian serous borderline tumor (SBT) harboring the V600E mutation is associated with a lower risk of progression to low-grade serous carcinoma. Preliminary observations suggest that there may be an association between eosinophilic cells (ECs) and the above-mentioned mutation, so this study aimed to evaluate interobserver reproducibility for assessing ECs. Forty-two samples of SBTs were analyzed for ECs with abundant eosinophilic cytoplasm.
View Article and Find Full Text PDFCombined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers.
Pharmaceutics
November 2023
Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), Schlossgarten 4, 91054 Erlangen, Germany.
Despite the availability of currently approved antiviral drugs, infections with human cytomegalovirus (HCMV) still cause clinically challenging, sometimes life-threatening situations. There is an urgent need for enhanced anti-HCMV drugs that offer improved efficacy, reduced dosages and options for long-term treatment without risk of the development of viral drug resistance. Recently, we reported the pronounced anti-HCMV efficacy of pharmacological inhibitors of cyclin-dependent kinases (CDKs), in particular, the potential of utilizing drug synergies upon combination treatment with inhibitors of host CDKs and the viral CDK-like kinase pUL97 (vCDK/pUL97).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!